[9] [8] Medical uses [edit] Setmelanotide is indicated for chronic weight management (weight loss and weight maintenance for at least one year) in people six years and older with obesity due to three rare genetic conditions: pro-opiomelanocortin (POMC) deficiency, proprotein subtilisin/kexin type 1 (PCSK1) deficiency, and leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes considered pathogenic (causing disease), likely pathogenic, or of uncertain significance
Legend may help: Improve joint lubrication and fluid quality Decrease inflammation within the joint Reduce lameness associated with joint irritation Support smoother, more comfortable movement Legend may be administered intravenously (IV) or directly into the joint (IA) depending on the condition being treated
This does not necessarily mean that tirzepatide will be the best option for everyone, as both drugs are effectiveand different people respond differently to each drug
Zepbound was approved in 2023 for chronic weight management in adults with obesity or with overweight and at least one weight-related condition
Always follow the specific instructions from your compounding pharmacy first
While research demonstrates ozone therapys potential for managing chronic joint conditions like arthritis and osteoarthritis, patients must weigh promising clinical outcomes against safety risks and regulatory considerations
